Can elevated concentrations of ALT and AST predict the risk of 'recurrence' of COVID-19?

L Z Chen1, Z H Lin2, J Chen3

  • 1Department of Infectious Disease, Qingdao Municipal Hospital Group, Qingdao, China.

Epidemiology and Infection
|September 21, 2020
PubMed

Insights

Elevated liver enzymes, specifically alanine aminotransferase (ALT) and aspartate aminotransferase (AST), may indicate an increased risk of coronavirus disease 2019 (COVID-19) recurrence. This finding offers insights for future prevention strategies.

Area of Science:

  • Medical Research
  • Infectious Diseases
  • Hepatology

Background:

  • The phenomenon of coronavirus disease 2019 (COVID-19) recurrence has garnered significant scholarly attention globally.
  • Understanding risk factors for COVID-19 recurrence is crucial for effective public health management.

Purpose of the Study:

  • To investigate potential clinical and biochemical markers associated with COVID-19 recurrence.
  • To identify specific indicators that may predict the likelihood of disease re-emergence in patients.

Main Methods:

  • A comparative study involving 44 COVID-19 recurrent cases and 32 control cases admitted between February and March 2020.
  • Analysis of demographic data, comorbidities, clinical symptoms, and liver enzyme concentrations (ALT and AST).

Main Results:

  • Recurrent COVID-19 cases showed significantly elevated concentrations of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) compared to controls.
  • Hypertension was the most common comorbidity in recurrent cases.
  • Fever and cough were prevalent symptoms in both groups.

Conclusions:

  • Elevated ALT and AST levels may serve as predictive markers for COVID-19 recurrence risk.
  • These findings could inform future strategies for the prevention and control of recurrent COVID-19 infections.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
101
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
613
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
399
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
94
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
119
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
331